Navigation Links
Sinovac Reports Unaudited First Quarter 2011 Financial Results
Date:5/13/2011

5 - research and development expenditures qualified for   government grant(73,390)(17,554) - depreciation of property, plant and equipment   and amortization of licenses and permits1,192,706891,007 - deferred government grant recognized in income (68,482)(65,830)- accretion expense101,845-Changes in: - accounts receivable46,5771,829,731 - inventories(2,281,688)(3,771,749) - income tax payable (refundable) (103,393)(2,628,408) - prepaid expenses and deposits(9,231)(335,770)- deferred revenue and advances from customers(302,680)(234,054) - accounts payable and accrued liabilities(2,878,114)(6,100,581)Net cash used in operating activities(7,689,736)(10,146,421)Cash flows from (used in) financing activities- Loan proceeds-8,265,031- Proceeds from issuance of common stock,   net of share issuance costs284,70961,867,706- Dividends paid to non-controlling shareholder of Sinovac Beijing(2,456,884)-- Government grant received -46,811- Loan to non-controlling shareholder of  Sinovac  Beijing -(6,572,159)Net cash provided by  (used in) financing activities(2,172,175)63,607,389Cash flows used in investing activities - Proceeds from disposal of equipment-189,876-  Proceeds from redemption of short-term investments-7,314,187-  Purchase of short-term investments-(8,338,173) - Deposits for acquisition of equipment(1,529)(8,265,031) - Acquisition of property, plant and equipment(1,153,348)(448,165)Net cash used in investing activities(1,154,877)(9,489,345)Exchange gain on cash and cash equivalents407,5997,630Increase in cash and cash equivalents(10,609,191)43,979,253Cash and cash equivalents, beginning of period101,585,49074,953,212Cash and cash equivalents, end of period$

90,976,299

$

118,932,465Cash paid for interest$

103,393

$

268,279Cash paid for income taxes$

306,017

$

1,653,353Supplemental schedule of non-cash activities:  Acquisition of property, plant and equipment in
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Sinovac Presents at Two Investor Conferences in May 2011
2. Sinovac Files Annual Report on Form 20-F
3. Sinovac Participates in UBS Greater China Healthcare Corporate Day
4. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
5. Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV)
6. Sinovac Provides Preliminary Unaudited Fourth Quarter 2010 Sales Range
7. Sinovacs Stock Exchange Listing Moves to NASDAQ Global Select Market
8. Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
9. Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
10. Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
11. Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 This ... for molecular imaging informatics solutions including nuclear imaging ... and comparison. The study assesses the size of ... 2010 and 2013, and projects future growth based ... as the dynamics taking place in the broader ...
(Date:9/30/2014)... BURLINGTON, Mass. , Sept. 30, 2014  Decision ... (PV) devices in Brazil , ... and China (BRIC) will see ... techniques are increasingly favored over surgical procedures. Although revenues ... care resources, reimbursement challenges, prolonged device approval times and ...
(Date:9/30/2014)... 2014  Alimera Sciences, Inc. (NASDAQ: ALIM ... research, development and commercialization of prescription ophthalmic pharmaceuticals, announced ... from Hercules Technology Growth Capital, Inc. (NYSE: ... final advance under the Loan and Security Agreement that ... , Alimera Sciences Limited, entered into with Hercules in ...
Breaking Medicine Technology:Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 2Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023 3Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2
... Planet Biopharmaceuticals, Inc. and its wholly owned Subsidiaries ... on providing products for allergy and asthma sufferers, today ... ALLERGY CONTROL PRODUCTS, INC., a Delaware corporation("ACP") to RH ... Theron E. Odlaug, Ph. D., CEO and ...
... Communication efforts on behalf of the public and private healthcare ... are today, according to a new book , "Health ... Nancy J. Hicks and Christina Mazzola Nicols of Ketchum ... The book, released this fall from Jones & ...
Cached Medicine Technology:New Book Highlights Opportunities for Healthcare Industry Communications 2New Book Highlights Opportunities for Healthcare Industry Communications 3New Book Highlights Opportunities for Healthcare Industry Communications 4New Book Highlights Opportunities for Healthcare Industry Communications 5
(Date:10/1/2014)... (PRWEB) October 01, 2014 Familylifeinsurancequotes.org ... find life insurance for senior citizens. , Senior ... Agencies will now sell coverage to seniors who are ... can be purchased without taking a medical examination. , ... purchased online and senior clients can qualify. Having life ...
(Date:10/1/2014)... Bedros Keuilian is not only the founder ... camps, he’s also considered the leading expert on marketing ... business summits, a line of high-demand fitness marketing systems ... Spike TV reality show to his name. , With ... for personal trainers and fitness business owners to focus ...
(Date:10/1/2014)... Phoseon Technology, the pioneer in developing ... the business worldwide. This rapid growth includes increased hiring ... manufacturing efforts. The company has experienced average annual growth ... expects this growth to continue in the future as ... adoption. , “We are very pleased that ...
(Date:10/1/2014)... Join the more than 80 golfers who already have ... charity golf tournament to benefit Project HEAL, a not-for-profit organization ... afford treatment. The tournament will be held Monday, Oct. 6, ... The day-long event starts with 10:30 a.m. check-in and shotgun ... begin at 5 p.m. and will include an auction featuring ...
(Date:10/1/2014)... Kennebunkport, Maine (PRWEB) October 01, 2014 ... autoimmune disorders in the U.S., according to figures from ... Autoimmune Related Diseases Association (AARDA), and many of them ... higher chance of having undiagnosed celiac disease. Gluten ... helping raise awareness of undiagnosed celiac disease by publishing ...
Breaking Medicine News(10 mins):Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 2Health News:Informative New Blog Series Underscores Link Between Celiac Disease and Other Autoimmune Disorders 3
... have to drink more to feel drunk than non-smoking ... their brains, livers and hearts, a new study suggests. ... rats, which are considered a good model for humans.Since alcohol ... more alcohol to get an expected level of intoxication, say ...
... study of the similarities and differences in disease patterns in ... We share many of our genes with our primate cousins ... similar in many ways, but dogs do not suffer from ... ,Professor Bob Michell is Professor of Comparative Medicine at ...
... a lot of drug-company money to tell doctors not to ... makes sense to involve the industry in a campaign that's ... unethical behavior. // ,At issue are the ... and trips, that some drug makers shower on doctors. Ethicists ...
... your genes, and everything to do with your upbringing say UK ... believed to be at least partly genetically determined - so researchers ... team asked 71 pairs of identical twins and 56 pairs of ... on a scale of 0 to 10.// A zero deemed the ...
... genome sequence suggests a route to new antibiotics, and ... even minor infections can become a major threat. There ... resistant bacteria.// ,Antibiotic resistance is a growing public ... from the soil bacteria Streptomyces , including erthyromycin and ...
... the Study of Aging and the International Longevity Center says ... advised to put down the pill bottle and pick up ... crossword puzzles, exercise and seek help for emotional problems may ... unproven cures such as melatonin, DHEA, testosterone and human growth ...
Cached Medicine News:
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: